2025-11-15T19:07:29-06:00 2024-12-31 274247106 INTEGROUS 704 Las Ovejas Avenue San Rafael CA 949033108 990 2024-01-01 821206912 The Ketamine Research Foundation KETA 4155501700 6 Crest Road San Anselmo CA 949602553 Philip E Wolfson MD CEO 4155501700 2025-11-15 1 0 Kian S Nobari P01702699 4152000900 2025-11-14 2024 2025-03-06 01:10:19Z Philip E Wolfson MD 6 Crest Road San Anselmo CA 949602553 674218 0 X www.ketamineresearchfoundation.com X 2017 CA The Ketamine Research Foundation's mission is the development of Ketamine's use for psychiatric and psychotherapeutic science and clinical practice, research, education, and training. 6 6 0 0 0 0 198695 323885 691065 349322 536 227 -5985 784 884311 674218 0 5750 0 0 172737 136500 0 0 15750 785968 499153 958705 641403 -74394 32815 527941 560755 1964 1964 525977 558791 X The specific purpose of the corporation shall include, without limitation: to evolve and provide research, training, and education in the development of Ketamine's use for psychiatric and psychotheraputic science and clinical practice. 0 0 252349 5000 14409 Ketamine is the only legally available medicine with psychedelic therapeutic methodologies and practices that will serve as a model and development ground as other psychoactive medicines become available for clinical practice. This makes for streamlined and creative research, with appropriate safeguards with FDA and IRB approvals as appropriate.KRF's 2024 achievements were as follows: Completed Phantom Limb Protocol and submitted it to FDAin Review. IRB gave conditional approval based on FDA review Our Acute Trauma PTSD protocol was sent, taught and utilized in the Ukraine, Israel, North Carolina's disaster and elsewhere. KRF took leadership in dealing with trauma treatment worldwide and presented its protocol and is providing ongoing training KRF's protocol for Women's Wellbeing with the treatment of luteal face PMS and PMDD was submitted to FDA for an INDin review Setting Standards for Safe and Effective Ketamine Use-- KRF as the standard bearer for the use of ketamine clinicallyAnd for its safe use personally. KRF published major articles on KAP in academic journals, participated in numerous podcasts and programs, and had several journalistic pieces published. 349701 750 334913 KRF's Ketamine Training Center continued its practitioner training programs with over 1000 persons trained as of 2024. Our 2nd Annual Dharma K program was held as well as our Advanced Sharing program. WE remain as the principle and most complete training organization for KAP and Ketamine work. The BIPOC program continues to support diversity with scholarship assistance to trainees.KRF's Ketamine Psychotherapy Associates membership program now has over 100 members and provides ongoing support for practitioners and KAP practices. Our Access to Care program provide funds for our members to support those who cannot afford care. 602050 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 11 0 1 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X Integrous 4152000900 704 Las Ovejas Avenue San Rafael CA 949033108 Monica Winsor Chair of the Board 2.00 X X 0 0 0 Ray Foote Treasurer 1.00 X X 0 0 0 Daniel Schwartz Secretary 1.00 X X 0 0 0 Michael Thatcher Director 1.00 X 0 0 0 Bruce Richman Director 1.00 X 0 0 0 Ethan Ruby Director 1.00 X 0 0 0 Philip E Wolfson MD CEO 20.00 X 136500 0 0 136500 0 0 1 0 0 0 0 323885 323885 Therapist Training 611430 349322 349322 349322 227 227 Merchandise 458000 784 784 784 674218 349322 0 1011 750 750 5000 5000 136500 105000 15750 15750 5000 5000 2166 1736 430 6761 6761 13000 11700 1300 1027 1027 5000 5000 89 89 4632 3706 926 Training 406618 406618 Clinical Research 54289 54289 Postagage, Mailing, Pri 463 463 Bank Fees 108 108 641403 602050 23603 15750 524941 557755 3000 3000 527941 560755 1964 1964 1964 1964 X 525977 558791 525977 558791 527941 560755 X 32815 -1 X 0 0 0 X 296392 435356 262761 198695 323885 1517089 106230 571958 625612 691065 349322 2344187 402622 1007314 888373 889760 673207 3861276 0 0 0 3861276 26143 137 202 536 227 27245 26143 137 202 536 227 27245 428765 1007451 888575 890296 673434 3888521 0.99300 0.99320 0.00700 0.00680 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 0 0 0 0 0 0 0 0 Form 990, Part VI, Section B, line 11b The CEO provides a copy of the Form 990 for the directors' review and reference prior to filing. They provide feedback to the CEO to be addressed as he/she would determine necessary Form 990, Part VI, Section B, line 12c Via email or other communications, the organization prompts the individuals subject to the policy to disclose any conflicts and monitors the responses Form 990, Part VI, Section B, line 15 The Executive Committee of the Board reviews the compensation of the CEO, other officers, and key employees, takeing into account comparative compensation and performance metrics Form 990, Part VI, Section C, line 19 The organization makes its governing documents and financial statements available upon request and considers all requests on a case by case basis Form 990, Part XI, line 9: Rounding adjustment -1.